Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer (EORTC 08984).

Source:http://linkedlifedata.com/resource/pubmed/id/16759850

Download in:

View as

General Info

PMID
16759850